HSIC Key Statistics, Chart & Performance
The current stock price of HSIC is 76.19 USD. In the past month the price increased by 0.91%. In the past year, price increased by 8.19%.
HSIC Latest News, Press Relases and Analysis
HSIC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 22.79 | 102.01B | ||
| COR | CENCORA INC | 21.26 | 65.95B | ||
| CAH | CARDINAL HEALTH INC | 23.29 | 49.31B | ||
| AHCO | ADAPTHEALTH CORP | 32 | 1.39B | ||
| OMI | OWENS & MINOR INC | 2.1 | 209.62M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 38.91M |
Related stock screener links
About HSIC
Company Profile
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 25,000 full-time employees. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.
Company Info
HENRY SCHEIN INC
135 Duryea Rd
Melville NEW YORK 11747 US
CEO: Stanley M. Bergman
Employees: 25000
Phone: 16318435500
HENRY SCHEIN INC / HSIC FAQ
Can you describe the business of HENRY SCHEIN INC?
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 25,000 full-time employees. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.
Can you provide the latest stock price for HENRY SCHEIN INC?
The current stock price of HSIC is 76.19 USD. The price decreased by -0.41% in the last trading session.
What is the dividend status of HENRY SCHEIN INC?
HSIC does not pay a dividend.
How is the ChartMill rating for HENRY SCHEIN INC?
HSIC has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Would investing in HENRY SCHEIN INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on HSIC.
What is HENRY SCHEIN INC worth?
HENRY SCHEIN INC (HSIC) has a market capitalization of 8.97B USD. This makes HSIC a Mid Cap stock.
HSIC Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to HSIC. When comparing the yearly performance of all stocks, HSIC is one of the better performing stocks in the market, outperforming 73.79% of all stocks.
HSIC Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to HSIC. There are concerns on the financial health of HSIC while its profitability can be described as average.
HSIC Financial Highlights
Over the last trailing twelve months HSIC reported a non-GAAP Earnings per Share(EPS) of 4.82. The EPS increased by 14.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.02% | ||
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| Debt/Equity | 0.91 |
HSIC Forecast & Estimates
22 analysts have analysed HSIC and the average price target is 78.7 USD. This implies a price increase of 3.3% is expected in the next year compared to the current price of 76.19.
For the next year, analysts expect an EPS growth of 5.82% and a revenue growth 2.47% for HSIC